NVACR NORTHVIEW ACQUISITION CORP COM USD0.0001 (SUB/RIGHTS)
- 0.0950
- -0.0100-9.52%
- 0.0950
- 0.00000.00%
NORTHVIEW ACQUISITION CORP COM USD0.0001 (SUB/RIGHTS) News
NorthView Acquisition Corporation Announces Receipt of Notice From Nasdaq Regarding Filing of Annual Report on Form 10-Q
New York, NY, June 07, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (NASDAQ:NVAC) (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq")
NorthView Acquisition Corp Announces Filing a Registration Statement on Form S-4 in Connection With a Proposed Business Combination With Profusa, Inc.
New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- NorthView Acquisition Corp (NASDAQ:NVAC) ("NorthView"), a publicly-traded special purpose acquisition company, and Profusa, Inc. ("Profusa"), a digital health company
Profusa, Inc., a Digital Health Company, Pioneering the Next Generation of Personalized Medicine, to Become a Publicly Traded Company Via Merger With NorthView Acquisition Corp
New York, New York, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Profusa, Inc. ("Profusa"), a digital health company that is pioneering the next generation of personalized medicine and NorthView Acquisition
Analysis
Price Target
No Data
